Dr. Jon Campbell: Understanding GIP and Glucagon | Ep. 14

In this episode of The GLP-1 Podcast Show, I speak with Dr. Jon Campbell, Associate Professor of Medicine at Duke University, about the changing science of GIP and glucagon. We examine GIP physiology, glucagon signaling, weight-independent metabolic effects, multi-receptor agonism, and variability in treatment response. Discover how emerging pharmacology could shape more precise obesity treatment. Listen now on all major platforms. *"GI think it’s going to take a little while, but people are going to come around to this idea that glucagon, particularly when combined with an incretin like GIP or GLP-1, is a really powerful way to improve metabolic disease."* **Meet the guest: *Dr. Jon Campbell*** is an Associate Professor of Medicine at Duke University. His research examines incretin hormones, pancreatic islet biology, and the cellular mechanisms that regulate glucose metabolism. His work has helped advance understanding of GIP, GLP-1, glucagon, and the signaling pathways that may shape future metabolic therapies. Listen to Dr. Jon Campbell on The GLP-1 Podcast Show, available on all major platforms. Want to stay up to date on the latest GLP-1 research and updates? Subscribe and never miss an episode. **What you will learn:** - (00:00) Highlight - (02:11) Introduction - (03:18) GIP biology - (07:13) Hormone contributions - (12:54) Optimized agonists - (16:42) Glucagon actions - (20:30) Multi-hormone therapies - (26:55) Closing thoughts **The GLP-1 Podcast Show** is trusted and supported by innovative companies like: \- Zentrix Insights \- ZentrixOS \- WiseVAs \- Elevate 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: The GLP-1 Podcast Show Instagram: The GLP-1 Podcast Show LinkedIn: The GLP-1 Podcast Show YouTube: The GLP-1 Podcast Show Facebook: The GLP-1 Podcast Show TikTok: The GLP-1 Podcast Show